Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Contribution of Va24Vb11 natural killer T cells in Wilsonian hepatitis.

Kinebuchi M, Matsuura A, Ohya K, Abo W, Kitazawa J.

Clin Exp Immunol. 2005 Jan;139(1):144-51.

2.

Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver.

Exley MA, He Q, Cheng O, Wang RJ, Cheney CP, Balk SP, Koziel MJ.

J Immunol. 2002 Feb 15;168(4):1519-23.

3.

NKT cells in the rat: organ-specific distribution of NK T cells expressing distinct V alpha 14 chains.

Matsuura A, Kinebuchi M, Chen HZ, Katabami S, Shimizu T, Hashimoto Y, Kikuchi K, Sato N.

J Immunol. 2000 Mar 15;164(6):3140-8.

4.

Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.

Durante-Mangoni E, Wang R, Shaulov A, He Q, Nasser I, Afdhal N, Koziel MJ, Exley MA.

J Immunol. 2004 Aug 1;173(3):2159-66.

5.

Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.

Wingender G, Berg M, J├╝ngerkes F, Diehl L, Sullivan BA, Kronenberg M, Limmer A, Knolle PA.

Eur J Immunol. 2006 Mar;36(3):570-82.

6.
7.
8.

Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.

Capone M, Cantarella D, Sch├╝mann J, Naidenko OV, Garavaglia C, Beermann F, Kronenberg M, Dellabona P, MacDonald HR, Casorati G.

J Immunol. 2003 Mar 1;170(5):2390-8.

9.

CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver.

Kenna T, O'Brien M, Hogan AE, Exley MA, Porcelli SA, Hegarty JE, O'Farrelly C, Doherty DG.

Cancer Immunol Immunother. 2007 Apr;56(4):563-72. Epub 2006 Aug 22.

PMID:
16924493
10.

Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.

Ikarashi Y, Mikami R, Bendelac A, Terme M, Chaput N, Terada M, Tursz T, Angevin E, Lemonnier FA, Wakasugi H, Zitvogel L.

J Exp Med. 2001 Oct 15;194(8):1179-86. Erratum in: J Exp Med 2001 Nov 5;194(9):1391.

11.

Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.

Osman Y, Kawamura T, Naito T, Takeda K, Van Kaer L, Okumura K, Abo T.

Eur J Immunol. 2000 Jul;30(7):1919-28.

12.

Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity.

Nieda M, Okai M, Tazbirkova A, Lin H, Yamaura A, Ide K, Abraham R, Juji T, Macfarlane DJ, Nicol AJ.

Blood. 2004 Jan 15;103(2):383-9. Epub 2003 Sep 25.

13.

A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.

Hameg A, Apostolou I, Leite-De-Moraes M, Gombert JM, Garcia C, Koezuka Y, Bach JF, Herbelin A.

J Immunol. 2000 Nov 1;165(9):4917-26.

14.

CD1d-restricted NKT cells: an interstrain comparison.

Hammond KJ, Pellicci DG, Poulton LD, Naidenko OV, Scalzo AA, Baxter AG, Godfrey DI.

J Immunol. 2001 Aug 1;167(3):1164-73.

15.

Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.

Mannoor MK, Weerasinghe A, Halder RC, Reza S, Morshed M, Ariyasinghe A, Watanabe H, Sekikawa H, Abo T.

Cell Immunol. 2001 Aug 1;211(2):96-104.

PMID:
11591113
16.
17.

Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer.

Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He XS, Koning F, Mikayama T, Van De Water J, Coppel RL, Kaplan M, Gershwin ME.

Gastroenterology. 2002 Oct;123(4):1031-43.

PMID:
12360465
18.

Control of NKT cell differentiation by tissue-specific microenvironments.

Yang Y, Ueno A, Bao M, Wang Z, Im JS, Porcelli S, Yoon JW.

J Immunol. 2003 Dec 1;171(11):5913-20.

19.

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.

Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, Kronenberg M, Seeger RC.

J Immunol. 2001 Sep 15;167(6):3114-22.

20.

CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.

Thomas SY, Hou R, Boyson JE, Means TK, Hess C, Olson DP, Strominger JL, Brenner MB, Gumperz JE, Wilson SB, Luster AD.

J Immunol. 2003 Sep 1;171(5):2571-80.

Supplemental Content

Support Center